Booming antibodies 2001
MasterControl - Learn How to Avoid Obstacles in Pharma Manufacturing
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

16

May 2022

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

Inmagene Biopharmaceuticals announces that today the US Food and Drug Administration FDA cleared its investigational new drug IND application for the drug candidate IMG a noncovalent reversible thirdgeneration Bruton Tyrosine Kinase BTK inhibitor to proceed to the Phase I clinical trial Inmagene is...

13

May 2022

Neurocrine Biosciences Receives Orphan Drug Designation for Valbenazine as a Treatment for Chorea Associated with Huntington Disease

Neurocrine Biosciences Inc announced that it has received Orphan Drug Designation from the US Food and Drug Administration FDA for valbenazine as a treatment for Huntington disease HD The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation In December Neurocri...

13

May 2022

Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014

Mindset Pharma Inc a drug discovery and development company focused on creating optimized and patentable nextgeneration psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs today announced that it is making headway in progressing its Family lead clinical ca...

12

May 2022

Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases

Nuvig Therapeutics Inc announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function To support this mission the company has closed a million Series A financing led by No...

12

May 2022

Neuvivo Begins Manufacturing of NP001 for Treatment of ALS

Neuvivo a biopharmaceutical company dedicated to delivering an effective safe ALS treatment to patients today announced that it has initiated cGMP manufacturing of NP for the treatment of ALS Lou Gehrigs Disease The company expects to have product available by the end of the year for clinical use P...

11

May 2022

Pfizer to Acquire Biohaven Pharmaceuticals

Pfizer Inc and Biohaven Pharmaceutical Holding Company Ltd announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven the maker of NURTEC ODT an innovative dualacting migraine therapy approved for both acute treatment and episodic prevention of mig...

press releasesRead more...

12

May 2022

Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers

Crown Bioscience and Medical Biological Laboratories MBL JSR Life Sciences companies today announced the formation of a joint venture to further expand the provision of Crown Biosciences preclinical services to Japanese customers The new entity named Crown Bioscience MBL is a longterm strategic pa...

12

May 2022

Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure

Roche through its Global Access Program and The Global Fund to Fight AIDS Tuberculosis and Malaria are joining forces to build and strengthen diagnostic capacity and pandemic preparedness in lowand middleincome countries fighting against HIV and tuberculosis TB About billion people worldwide are es...

12

May 2022

Sun Pharma Announces US FDA Approval for Generic Mesalamine Extended Release Capsules

Sun Pharmaceutical Industries Limited today announced that it has received final approval from US FDA for its Abbreviated New Drug Application ANDA for generic Mesalamine Extended Release Capsules mg The generic product approval is based on Pentasa Extended Release Capsules mg as a reference produ...

12

May 2022

Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Beta Thalassemia

Editas Medicine Inc a leading genome editing company today announced that the US Food and Drug Administration FDA granted Orphan Drug Designation to EDIT an investigational gene editing medicine for the treatment of beta thalassemia The FDA previously granted Rare Pediatric Disease designation to ED...

12

May 2022

Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics

Skye Bioscience Inc and Emerald Health Therapeutics Inc announced today that the companies have entered into a definitive agreement with respect to a transaction to be completed by way of a Plan of Arrangement the Arrangement whereby Skye would acquire all of the issued and outstanding shares of Eme...

12

May 2022

BridgeBio Announces Exclusive License Agreement with Bristol Myers Squibb to Develop and Commercialize BBP-398, a Potentially Best-in-Class SHP2 Inhibitor, in Oncology

BridgeBio Pharma Inc a commercialstage biopharmaceutical company focused on genetic diseases and cancers announced today an exclusive license with Bristol Myers Squibb to develop and commercialize BBP a potentially bestinclass SHP inhibitor in oncology Under the terms of the agreement BridgeBio will...

EventsRead more...

18 - 22

May 2022

Cognitive Neuroscience

Helsinki Workers' House

23 - 24

May 2022

24 - 26

May 2022

26 - 29

May 2022

27 - 29

May 2022

30 - 01

May 2022

Gene Therapy Analytical Development

Hanson Wade
Victoria Park Plaza Hotel

01 - 03

Jun 2022

PharmaLytica 2022

Bombay Exhibition Centre

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Porton Pharma Solutions and Codexis Launch Global Partnership

    PARTNERSHIP

    Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing business The partnership will accelerate the creation and commercialization of new lowcost sustainable manufacturing processes exploiting the benefits of...
  • Articles

    Single Domain Antibody

    Monoclonal and polyclonal antibodies Abs are wellcorroborated tools adopted in basic biomedical research and innovative key components of numerous therapeutic platforms today on the market The vast majority of the Abs are obtained from easily accessible laboratory animals such as mice hamsters and rabbits and consist of two heavy and two light chains

  • Techno Trends

    First Digital Pill Tracks Patients Medication

    Abilify MyCite the first digital pill with a sensor digitally tracks if patients have taken their medication Abilify MyCite also gets an approval from the US Food and Drug Administration FDA This first digital pill is fitted with a digital ingestion tracking system and has an ingestible sensor embedded in the pill that records that the medication was taken The A...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...